Winthrop Jackman

Title: Winthrop Jackman: Innovator in Biopharmaceuticals

Introduction

Winthrop Jackman is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of biopharmaceuticals, holding a total of 2 patents. His work primarily focuses on innovative compositions and processes related to gp350 proteins.

Latest Patents

Jackman's latest patents include advancements in non-splicing variants of gp350/220. These patents provide compositions comprising gp350 variant DNA and amino acid sequences. They also detail vectors and host cells containing such sequences. Furthermore, the patents describe a process for producing homogeneous gp350 protein recombinantly, specifically in the absence of gp220 protein. This innovation extends to pharmaceutical compositions containing such proteins and their use in prophylactic treatments.

Career Highlights

Throughout his career, Winthrop Jackman has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with MedImmune Vaccines, Inc. and Aviron. His expertise in the field has allowed him to contribute to significant advancements in vaccine development and protein engineering.

Collaborations

Jackman has collaborated with various professionals in his field, including Richard R. Spaete. These collaborations have further enhanced his research and development efforts in biopharmaceutical innovations.

Conclusion

Winthrop Jackman stands out as an influential inventor in the biopharmaceutical industry. His patents and career achievements reflect his commitment to advancing medical science through innovative solutions.